Pyridonecarboxylic acid derivatives and intermediates for the synthesis
thereof
    2.
    发明授权
    Pyridonecarboxylic acid derivatives and intermediates for the synthesis thereof 失效
    吡啶酮羧酸衍生物及其合成中间体

    公开(公告)号:US6017911A

    公开(公告)日:2000-01-25

    申请号:US125765

    申请日:1998-08-25

    CPC分类号: C07D491/04

    摘要: This invention relates to pyridonecarboxylic acid derivatives of the following general formula, esters thereof and salts thereof, as well as pharmaceutical preparations containing them. ##STR1## wherein: R is cycloalkyl which may be substituted by halogen, or the like;X is hydrogen, lower alkyl, amino or the like;Y is hydrogen or halogen;A is nitrogen or a group of the formula C--Z in which Z is lower alkoxy that may be substituted by halogen, or the like;R.sub.1 and R.sub.2 may be the same or different and are each hydrogen or the like;R.sub.3 is hydrogen or lower alkyl;R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8 and R.sub.9 may be the same or different and are each hydrogen, halogen or lower alkyl;m is 0 or 1; andn and p may be the same or different and are each 0 or 1.This invention also relates to bicyclic amine compounds useful as direct intermediates for the synthesis of the above-described pyridonecarboxylic acid derivatives.

    摘要翻译: PCT No.PCT / JP97 / 00530 Sec。 371日期:1998年8月25日 102(e)日期1998年8月25日PCT提交1997年2月25日PCT公布。 第WO97 / 31919号公报 1997年9月4日,本发明涉及以下通式的吡啶酮羧酸衍生物,其酯类及其盐,以及含有它们的药物制剂。 其中:R为可被卤素取代的环烷基等; X是氢,低级烷基,氨基等; Y是氢或卤素; A是氮或式C-Z的基团,其中Z是可被卤素取代的低级烷氧基等; R1和R2可以相同或不同,各自为氢等; R3是氢或低级烷基; R 4,R 5,R 6,R 7,R 8和R 9可以相同或不同,各自为氢,卤素或低级烷基; m为0或1; n和p可以相同或不同,各自为0或1.本发明还涉及可用作合成上述吡啶酮羧酸衍生物的直接中间体的双环胺化合物。

    Compounds, processes for the preparation thereof and anti-tumor agents
    4.
    发明授权
    Compounds, processes for the preparation thereof and anti-tumor agents 失效
    化合物,其制备方法和抗肿瘤剂

    公开(公告)号:US5817669A

    公开(公告)日:1998-10-06

    申请号:US765232

    申请日:1996-12-13

    CPC分类号: C07D471/04

    摘要: This invention relates to pyridone-carboxylic acid derivatives of the following formula or salts thereof: ##STR1## wherein R.sub.1 is a hydrogen atom, a halogen atom, etc., R.sub.2 is a carboxyl group etc., R.sub.3 is a hydrogen atom etc., A is a nitrogen atom or CH, m is 1 or 2, and Y is an eliminable group or a group having the following formula: ##STR2## wherein R.sub.4 is a hydrogen atom or a lower alkyl group, Z is a hydrogen atom, a lower alkyl group, etc., R.sub.5 is a hydrogen atom, a lower alkyl group, etc., n is 0 or 1, and p is 1, 2, 3 or 4 and to processes for the preparation of these compounds, and further to anti-tumor agents which contain the above compounds as effective ingredients.

    摘要翻译: PCT No.PCT / JP95 / 01110 Sec。 371日期1996年12月13日第 102(e)日期1996年12月13日PCT归档1995年6月6日PCT公布。 公开号WO95 / 34559 日期:1995年12月21日本发明涉及下式的吡啶酮羧酸衍生物或其盐:其中R 1为氢原子,卤素原子等,R 2为羧基等,R 3为 氢原子等,A是氮原子或CH,m是1或2,Y是可消除的基团或具有下式的基团:其中R 4是氢原子或低级烷基,Z是 氢原子,低级烷基等,R5为氢原子,低级烷基等,n为0或1,p为1,2,3或4,制备这些物质的方法 化合物,还有含有上述化合物作为有效成分的抗肿瘤剂。